Vijaya Diagnostic Centre Ltd. Share Price

Overview

Vijaya Diagnostic Centre Ltd. share price is currently ₹1,538.75, up by ₹50.94 (3.42%) from its previous closing price of ₹1,487.81. The share price has gained 3.72% over the past month and gained 47.57% over the past year. The stock's 52-week low and high are ₹831.02 and ₹1,557.70, respectively. Vijaya Diagnostic Centre Ltd. has a market capitalisation of ₹ 15,470.00 Cr. The share price was last updated on 18 Sep 2026, 02:54 PM IST.

Vijaya Diagnostic Centre Ltd.
Vijaya Diagnostic Centre Ltd.
VIJAYA
 0.00
 50.94
3.42%
Healthcare
 0.00(%)1D

Updated: 18 Sep 2026, 02:54:45 pm IST

Market Data

Open Price

 1,498.08

Prev. Close

 1,487.81
 1,478.87

Day Low

 1,548.67

Day High

 831.02

52 Week Low

 1,557.70

52 Week High

HealthcareHospital & Healthcare Services
CategoryMid Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

84.36

Sector PE

44.64

PB Ratio

16.59

Sector PB

5.99

EPS

18.24

Dividend Yield

0.23

Today's Volume

222.234 K

5 Day Avg. Volume

157.090 K

PEG Ratio

4.22

Market Cap.

₹ 15,470.00 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

ActionsEx-DateRecord-Date
DividendsFinal Dividend of 200% at ₹2/Share
16-Sep-202616-Sep-2026
DividendsFinal Dividend of 200% at ₹2/Share
29-Aug-202529-Aug-2025
DividendsFinal Dividend of 100% at ₹1/Share
30-Aug-202430-Aug-2024

Mutual Fund Ownership

Mutual Fund Holder
Jul 26
Shares held
Aug 26
Shares held
Kotak Small Cap Fund - Growth54.55 Lac
54.55 Lac
no change
HDFC Small Cap Fund - Regular Plan - Growth45.16 Lac
46.16 Lac
(2.21%)
Nippon India Multi Cap Fund - Growth30.01 Lac
29.14 Lac
(2.91%)
HSBC Small Cap Fund - Regular Plan - Growth22.28 Lac
25.04 Lac
(12.38%)
Axis Small Cap Fund - Regular Plan - Growth20.62 Lac
20.62 Lac
no change

About Vijaya Diagnostic Centre Ltd. 👋

Vijaya Diagnostic Centre Limited is an India-based company, which is engaged in the business of providing a range of diagnostic services, spanning pathological investigations, basic and high-end radiology, nuclear medicine, and related healthcare services. It operates through the Diagnostic Services segment. It offers laboratory services and radiology services. Its services include clinical pathology, microbiology, hematology, serology, histopathology, cytogenetics, biochemistry, molecular diagnostics, computerized tomography (CT) scan, magnetic resonance imaging (MRI) scan, ultrasound, X-ray, cardiology, gastroenterology, nuclear medicine, and MRI-3T. It operates approximately 160 diagnostic centers in 25 cities spread across India. Its clinical pathology includes liver function test (LFT-A), creatine kinase (CPK) test, and thyroid profile test. It offers various health checkups, which include general wellness, women's care, gynecology packages, and lifestyle.

Expert Opinions

Insights from SEBI-registered analysts · updated live

Explore all →
RAJIV GUPTA (SEBI RA)

RAJIV GUPTA (SEBI RA)

13 Sep • 3:38 PM · SEBI-Registered Analyst

100% acquisition of the integrated diagnostic business

Code BSE: 543350 NSE:

VIJAYA
Vijaya Diagnostic Centre Makes Strategic Foray into Assam, Strengthening its Eastern India Presence through the Acquisition of B2C Focused Integrated Diagnostic Centre, Arya Wellness Centre in Guwahati Commenting on the acquisition, Ms. Suprita Reddy, Managing Director & CEO, Vijaya Diagnostic Centre Limited, said: Our entry into Guwahati marks another important milestone in Vijaya’s journey towards building a highquality, integrated diagnostics network. We have consistently pursued a disciplined approach to expansion, focusing on markets with strong long-term demand for comprehensive and advanced diagnostic services. Guwahati is a natural strategic extension of our growing presence in West Bengal and provides an attractive gateway to the North-East. Arya Wellness Centre has been built on an ethos that closely aligns with Vijaya’s philosophy of delivering high-quality diagnostics. It is a unique asset in Guwahati with a balanced mix of advanced and basic pathology and radiology services, making it a strategically attractive asset for us. We believe this acquisition provides Vijaya with a strong platform to establish a meaningful presence in Assam and progressively expand across the North-Eastern region.

See More
Akhilesh Jat SEBI RA

Akhilesh Jat SEBI RA

8 Aug • 9:06 PM · SEBI-Registered Analyst

🔬 Vijaya Diagnostic Faces Volatile Session Despite Strong Q1 Performance

On 7 August 2026,

VIJAYA
witnessed sharp intraday volatility following its Q1 FY27 earnings announcement. The stock initially rallied nearly 4.6% as investors reacted positively to the results, but the momentum faded through the session. The stock eventually slipped into negative territory, closing 1.37% lower on Friday and ending almost 3.8% below its intraday high. 📊 Q1 FY27 Highlights (Consolidated YoY): • Profit surged 37.6% to ₹53.1 crore from ₹38.6 crore. • Revenue jumped 22.8% to ₹231 crore from ₹188 crore. While the strong earnings triggered early buying interest, profit-booking and broader market dynamics weighed on the stock later in the day. Despite the volatile session, Vijaya Diagnostic has remained a notable outperformer in CY2026, with the stock advancing more than 27% year-to-date. 📌 Disclaimer: This content is for information only and not investment advice. Investments in securities market are subject to market risks. Read all the related documents carefully before investing. Please consult a SEBI-registered advisor before making any investment decisions.

See More
PATEL ABHIKUMAR HARESHBHAI

PATEL ABHIKUMAR HARESHBHAI

13 Jul • 11:55 AM · SEBI-Registered Analyst

Daily Index View : NIFTY50 as on 13/07/2026

1. Market Trend PROBABILITY 🚨 Current Market Trend: Positive 🚀 5% 🔍 Key Level to Watch: 24099 🔄 Current Market Surface: The trend will stay Positive until the market stay above 24099 That’s 108 points away from the last day Closing Price of 24207 ATR 268 2. Demand & Supply PROBABILITY Force is Demand & Supply is High 15% Last 3 days market has been flatish compared to ATR, so demand has very strong firepower — it just needs sentiment support 10 Jul 2026 FII Cash-net (Buy/sell) DII Cash- net (BUY/SELL) +2,603.72 +2,019.68 3. Reflexivity PROBABILITY First Half is Mildly Supportive to Bullish Momentum for at least first half 5% Last day market rallied Intraday around 25–50% of the 8-day average ATR, so it should keep its momentum intact in the first half 4. Social Proof (Global) PROBABILITY Dow Jones (Last day close) 48185 Up/Donw by 14 -42% Dow jones future (live) 52,724 Up/Donw by -182 Hang seng (Live) 24175 Up/Donw by -64 Nikki 225 (Live) 67187 Up/Donw by -1,371 Sentiments: Dow Jones Futures is Trading Flat to Negative & HANG SENG Index is trading Flat to Negative Today, global markets are neutral to slightly positive, and the Indian market has no strong directional bias Top stock to watchout

VIJAYA

See More
Lovelesh Sharma

Lovelesh Sharma

3 Jul • 10:47 AM · SEBI-Registered Analyst

VIJAYA
- In a range of Swing HL

Vijaya has formed a higher swing low around ₹1,311, indicating buyers are stepping in at higher levels and the broader uptrend remains intact. The recent swing high and immediate resistance is near ₹1,415, where the stock has faced selling pressure multiple times. A decisive close above ₹1,415 could trigger fresh momentum, while holding above the ₹1,311 swing low keeps the bullish structure intact.

See More
Shrikant Pandey

Shrikant Pandey

1 Jul • 12:18 PM · SEBI-Registered Analyst

VIJAYA

VIJAYA DIAGNOSTIC CENTRE LTD — abrdn Asia Reduces Stake 📊 abrdn Asia Limited sold 1,33,199 shares via open market on June 29, 2026 Stake reduced from 3.3667% to 3.2373% Company’s total equity share capital remains ₹10.29 Cr Transaction executed under SEBI (SAST) disclosure norms Impact: Neutral – minor institutional selling with no material impact on business fundamentals or control structure.

See More
Akhilesh Jat SEBI RA

Akhilesh Jat SEBI RA

28 Jun • 3:22 PM · SEBI-Registered Analyst

Vijaya Diagnostic Extends Winning Streak, Trades Near Record Highs

Shares of

VIJAYA
continued their upward momentum on June 25, 2026, closing 4.21% higher and marking their second consecutive winning session. The stock surged as much as 4.78% intraday to touch ₹1,375.30 before ending the day with strong gains. Notably, the stock is hovering close to its all-time high of ₹1,427.80 recorded on June 5, 2026, reflecting sustained investor confidence and strong price strength. The broader trend remains impressive. From its recent swing low of ₹848 recorded on March 30, 2026, the stock rallied nearly 68% to its lifetime high, highlighting a powerful uptrend over the past three months. Despite the sharp run-up, prices continue to hold near elevated levels, indicating persistent buying interest and a strong underlying trend. The stock’s ability to sustain gains near record highs will remain a key area of focus for market participants in the coming sessions. 📌 Disclaimer: This content is for information only and not investment advice. Investments in securities market are subject to market risks. Read all the related documents carefully before investing. Please consult a SEBI-registered advisor before making any investment decisions.

See More

News & Events

Frequently Asked Questions

What is the share price of Vijaya Diagnostic Centre Ltd.?

What is the market cap of Vijaya Diagnostic Centre Ltd.?

Should I buy Vijaya Diagnostic Centre Ltd. stock now?

What is the 52 week high and low of Vijaya Diagnostic Centre Ltd.?

Is the Vijaya Diagnostic Centre Ltd. stock good to buy?

Is Vijaya Diagnostic Centre Ltd. a good buy for the long term?

Is Vijaya Diagnostic Centre Ltd. overvalued or undervalued?

What is the PE and PB ratio of Vijaya Diagnostic Centre Ltd.?

Start Now